<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03665792</url>
  </required_header>
  <id_info>
    <org_study_id>CINI-ZYLX-201806-11</org_study_id>
    <nct_id>NCT03665792</nct_id>
  </id_info>
  <brief_title>The Correlation Between Sevoflurane and qNOX</brief_title>
  <official_title>The Prospective Observational Research of the Analgesic Effect of Sevoflurane and the Correlation Between Sevoflurane and qNOX</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China International Neuroscience Institution</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China International Neuroscience Institution</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study purpose to observation the sevoflurane analgesia effect, and using nociception
      real-time monitoring NOX to test the correlation between the sevoflurane and NOX index.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study purpose to observation the sevoflurane analgesia effect, and using nociception
      real-time monitoring NOX to test the analgesia effect of the sevoflurane.

      And test the correlation between the sevoflurane and NOX index.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 11, 2019</start_date>
  <completion_date type="Actual">September 1, 2019</completion_date>
  <primary_completion_date type="Actual">September 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The sevoflurane application correlated with the qNOX index</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>The sevoflurane application correlated with the qNOX index, meanwhile reflect the analgesia effect of sevoflurane application</description>
  </primary_outcome>
  <enrollment type="Actual">58</enrollment>
  <condition>Analgesic Adverse Reaction</condition>
  <condition>Nociceptive Pain</condition>
  <condition>Inhalation; Vapor</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nociception index qNOX</intervention_name>
    <description>non-invasive, real time, monitoring for nociception stimulation</description>
    <other_name>CON , BIS</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        only elective thoracoscope surgery patients were enrolled
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Elective thoracoscope surgery patients

          2. Age ranging from 25 to 85 years

          3. American Society of Anesthesiologists (ASA) Physical Status score of 2 to 4

          4. a body mass index (BMI) ranging from 18.5 to 40 kg/m2.

        Exclusion Criteria:

          1. Clinical diagnosis of Alzheimer's Disease

          2. implanted pacemaker

          3. Clinical diagnosis of psychiatric diseases

          4. Clinical diagnosis of epilepsy

          5. Clinical diagnosis of autonomic nervous system disorders which might affect the EEG
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaohua Wang, MD,PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xuanwu Hospital, Beijing</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bei Liu</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100053</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>August 4, 2018</study_first_submitted>
  <study_first_submitted_qc>September 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 11, 2018</study_first_posted>
  <last_update_submitted>January 20, 2020</last_update_submitted>
  <last_update_submitted_qc>January 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nociceptive Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

